Date: 07-Aug-2019

Indians big pharma companies finding new growth opportunities in China

ndian pharmaceutical companies are finding lucrative opportunities for growth in the Chinese pharma market, which is set to rise from nearly US$132bn in 2018 to more than US$209bn by 2022, says GlobalData, a leading data and analytics company.